Skip to main content

ADVERTISEMENT

Recombinant Human Epidermal Growth Factor

Review
01/22/2024

Meng-Wei Ge, MSc1; Fei-Hong Hu, MSc1; Yi-Jie Jia, MSc1; Wen Tang, MSc1; Wan-Qing Zhang, MSc1; and Hong-Lin Chen, PhD2

Meng-Wei Ge, MSc1; Fei-Hong Hu, MSc1;...
01/22/2024
Wound Management & Prevention
Original Research
02/02/2021
Maria Teresa Cacua Sanchez
Luis Fernando Giraldo
Jhon Alejandro Díaz
The objective of this descriptive, retrospective case series was to determine the efficacy of recombinant human epidermal growth factor plus compression therapy vs standard of care in 48 patients with active ulcers resulting from chronic...
The objective of this descriptive, retrospective case series was to determine the efficacy of recombinant human epidermal growth factor plus compression therapy vs standard of care in 48 patients with active ulcers resulting from chronic...
The objective of this...
02/02/2021
Wounds
Case Report
01/21/2019

María Teresa Cacua Sánchez, MD1; Luis Fernando Giraldo, RN2

1Peripheral Vascular Surgeon, Universidad El Bosque, Specialist in Healthcare Management, Universidad Sergio Arboleda, Centro de Cirugia Ambulatoria IPS (C.C.A.), Centro Medico Nuestra IPS, Bogotá, Colombia; 2Professional Nurse, Pontificia Universidad Javeriana University Teaching Specialist, Clinica de Heridas Giraldo, Bogotá, Colombia

María Teresa Cacua Sánchez, MD1; Luis...
This study describes the results in the healing of venous ulcers with the perilesional and intralesional use of nepidermin in patients with a class VI venous insufficiency diagnosis.
This study describes the results in the healing of venous ulcers with the perilesional and intralesional use of nepidermin in patients with a class VI venous insufficiency diagnosis.
This study describes the results...
01/21/2019
Vascular Disease Management
Original Research
07/01/2006
Wounds